Clinical Trial

A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated January 15, 2026 (before its estimated February 22, 2026 completion). Its status may not reflect the trial's current state.
Summary
Drug-Drug Interaction between DW4421 and three different kinds of NSAIDs
Trial Details
NCT Number NCT07343245
Lead Sponsor Daewon Pharmaceutical Co., Ltd.
Conditions Healthy Adult
Enrollment 150 participants
Start Date 2025-12-01
Primary Completion 2026-02-22 (estimated)
Study Completion 2026-06-17 (estimated)
Updated on ClinicalTrials.gov 2026-01-15